The world’s buzziest diabetes drug may accelerate the progression of diabetic retinopathy, according to a recent study presented at a conference of eye health experts. The results, from a new…

Medtronic is facing a class-action lawsuit alleging that the diabetes tech manufacturer illegally sold users’ personal information. Medtronic, of course, is a giant in the diabetes tech world, perhaps best…